Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Erythromycin; Tretinoin
Almirall Ltd
D10AF52
Erythromycin; Tretinoin
40mg/1gram ; 250microgram/1gram
Cutaneous solution
Cutaneous
No Controlled Drug Status
Valid as a prescribable product
BNF: 13060100; GTIN: 5000167025101
PACKAGE LEAFLET: INFORMATION FOR THE USER AKNEMYCIN ® PLUS Erythromycin Ph Eur 4.0% w/w and Tretinoin Ph Eur 0.025% w/w Solution WHAT IS IN THIS LEAFLET : 1. What Aknemycin Plus is and what it is used for 2. What you need to know before you use Aknemycin Plus 3. How to use Aknemycin Plus 4. Possible side effects 5. How to store Aknemycin Plus 6. Contents of the pack and other information 1. WHAT AKNEMYCIN PLUS IS AND WHAT IT IS USED FOR Aknemycin Plus is a treatment for acne which is applied to the skin. Aknemycin Plus is a solution and contains Erythromycin and Tretinoin as active ingredients. Erythromycin is an antibiotic which kills the germs found in acne and reduces the inflammation of your skin. Tretinoin encourages the layer of dead and hardened skin cells that form on the skin surface to peel off. At the same time, it clears the blackheads which block your skin pores and cause spots to form. Once the pore is unblocked, sebum can escape so that germ activity is limited. Aknemycin Plus also helps dissolve away the excess oil in your skin. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE AKNEMYCIN PLUS DO NOT USE AKNEMYCIN PLUS if you are allergic (hypersensitive) to Erythromycin, Tretinoin or any of the other ingredients of Aknemycin Plus (listed in section 6). if you are suffering from acute eczema, rosacea (a skin disease which affects the face and is characterised by redness, pimples and peeling) or acute inflammatory conditions of the skin, especially around the mouth. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any of the side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. if your skin is sunburnt. if you are using Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Aknemycin Plus 4.0% w/w and 0.025% w/w cutaneous solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each gram of cutaneous solution contains 40 mg of erythromycin and 0.25 mg of tretinoin. Excipients with known effect: 1 ml of solution contains 752 mg of alcohol (ethanol). For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Cutaneous solution. Aknemycin Plus is a clear solution for topical administration. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Aknemycin Plus is indicated for the treatment of all forms of acne, both non-inflammatory forms with comedones and inflammatory forms with papules and pustules particularly those associated with a very oily skin. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology To be applied to the affected areas once or twice daily. Treatment should continue for 9-12 weeks according to the condition of the skin. It should be noted that therapeutic improvement may not be observed for several weeks after starting treatment. Consistent application makes a significant contribution to the success of the therapy. Excess application of Aknemycin Plus should be avoided since it may result in marked erythema, drying and discomfort of the treated areas. The dosage is the same for all ages. Method of administration For application to the skin. The applicator allows direct administration to the skin. The patient should press the top of the screw cap on the foam pad before each use and should feel a 'click' which indicates that the applicator will close again automatically. 4.3 CONTRAINDICATIONS • Hypersensitivity to the active substances or to any of the excipients listed in section 6.1. • A family history of cutaneous epithelioma. • In acute eczemas, rosacea and acute inflammatory conditions of the skin, especially around the mouth. • When underlying sunburn is present • Concomitant use with other skin medications particularly those containing keratolytic agents (see section 4.5). • P Read the complete document